Intraocular Injection of StivantⓇ (A Biosimilar to Bevacizumab): A Case Series

PURPOSE: To report the results of intravitreal injection of a bevacizumab biosimilar called StivantⓇ METHODS: This prospective interventional case series was conducted on eyes with neovascular age-related macular degeneration (nAMD), retinal vein occlusion (RVO), and diabetic macular edema (DME). St...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Ophthalmic Vis Res
Glavni autori: Mirshahi, Ahmad, Lashay, Alireza, Riazi-Esfahani, Hamid, Ebrahimiadib, Nazanin, Khojasteh, Hassan, Ghassemi, Fariba, Bazvand, Fatemeh, Khodabande, Alireza, Roohipour, Ramak, Pour, Elias Khalili, Faghihi, Hooshang
Format: Artigo
Jezik:Inglês
Izdano: PUBLISHED BY KNOWLEDGE E 2021
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7841280/
https://ncbi.nlm.nih.gov/pubmed/33520125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18502/jovr.v16i1.8248
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items